Nested Therapeutics
4 known investors
Nested Therapeutics is a precision oncology company developing small-molecule cancer therapeutics by identifying overlooked driver mutations and novel binding pockets through a drug discovery platform combining genomics, computational biophysics, machine learning, and chemical biology. Its lead program, NST-628, is a brain-penetrant pan-RAF/MEK molecular glue in Phase 1 trials for MAPK-driven solid tumors, alongside a mutation-selective p53-pathway program.
AI & Machine LearningBiotechHealthtech
Founders & leadership
DM
Darrin MilesChief Executive Officer
PK
Philip KomarnitskyChief Medical Officer
TW
Tanja WeberChief Business Officer
AD
Arvin DarCo-founder & Board Observer
KS
Kevan ShokatScientific Co-founder
KH
Klaus HoeflichCo-founder & former Chief Scientific Officer
Investors · 4
In the news
Frequently asked questions
- What does Nested Therapeutics do?
- Nested Therapeutics is a precision oncology company developing small-molecule cancer therapeutics by identifying overlooked driver mutations and novel binding pockets through a drug discovery platform combining genomics, computational biophysics, machine learning, and chemical biology. Its lead program, NST-628, is a brain-penetrant pan-RAF/MEK molecular glue in Phase 1 trials for MAPK-driven solid tumors, alongside a mutation-selective p53-pathway program.
- Who are Nested Therapeutics's investors?
- Nested Therapeutics's investors include Versant Ventures, Foresite Capital, Cowen Healthcare Investments, Goldman Sachs.